1. Left main stenting using drug-eluting stents: long term outcome in an unselected cohort of patients from a tertiary medical center stratified by Syntax scoring
- Author
-
Jon Robken, Peter Sharis, Daniella Vigliotti, Cara M. Voelliger, Nicolas W. Shammas, Luay Mrad, Anita Ahuja, and Michael Jerin
- Subjects
medicine.medical_specialty ,Pediatrics ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Physical examination ,General Medicine ,Ablation ,Wound infection ,Surgery ,Safety profile ,Under local anaesthesia ,Patient age ,Cohort ,Varicose veins ,medicine ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Abstract
consecutive patients who underwent EVLT for short saphenous varicose veins in our department. A total of 59 consecutive procedures were performed in 52 patients during the study period. Patient age ranged from 21 to 86 (mean 51) years. All procedures were performed under local anaesthesia. Vein lengths treated ranged from 4 to 35 (mean 19) cm. The median amount energy utilized for venous ablation was 74 (range 60–88) J/cm. Results: No complications were encountered in any patients, apart from a single patient suffering from a wound infection. Follow up periods ranged from 2 to 24 months. A single recurrence was detected on clinical examination and duplex evaluation. Conclusion: EVLT is not only an effective option for SSV but has a very good safety profile. Recurrence rates are minimal and our interim results support this.
- Published
- 2012